Machinary - News

The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.

space id launches first ton based domain names on duckchain

SPACE ID has launched its first TON-based domain name service on DuckChain, enhancing digital identity for users within the TON ecosystem. This integration allows for seamless asset transfers using user-friendly domain names, improving security and user experience. Additionally, it marks the first use of $TON for domain pricing, supporting broader interoperability across blockchains.

Crypto News Flash

SPACE ID USD SGP Harrison Seletsky

Technology & Innovation, Press Release

16:37 19.12.2024

dow jones attempts recovery as micron plunges and nvidia rebounds

The Dow Jones Industrial Average attempted to recover from a significant 1,100-point drop, gaining 0.4% after a 2.6% decline. Micron's shares plummeted 17% following disappointing earnings guidance, while Nvidia rebounded 2.4% after five days of losses. Economic indicators showed a surprising 3.1% GDP growth and lower jobless claims, but market volatility persisted.

Investor's Business Daily

United States Dollar Vertex Pharmaceuticals Inc Tesla, Inc. USA Kimberley Koenig Show more

Finance & Economy, Market Report

16:34 19.12.2024

Sandoz settles US antitrust litigation for 275 million dollars

Sandoz has reached a $275 million settlement with the end-payer plaintiffs' class in the U.S. Generic Drug Antitrust Class Action litigation, resolving claims related to alleged anticompetitive conduct from 2009 to 2019. This agreement, which includes no admission of wrongdoing, is subject to court approval and follows previous settlements with the U.S. Department of Justice and direct purchaser plaintiffs. Additionally, Sandoz has set aside $265 million for outstanding claims from opt-out plaintiffs and state attorneys general.

Drug Store News

United States Dollar Sandoz Group AG USA CAN

Regulatory & Legal, Press Release

16:33 19.12.2024

boost vc invests in poscidondao to advance decentralized scientific research

Boost VC has invested in PoSciDonDAO, integrating it into their Go-To-Market Program to enhance decentralized scientific research. This partnership aims to promote equity and inclusivity in science through blockchain technology, providing mentorship, market insights, and networking opportunities. PoSciDonDAO focuses on democratizing personalized medicine research by ensuring transparent resource allocation.

Crypto News Flash

PAN Adam Draper Brayton Williams

Technology & Innovation, Press Release

16:33 19.12.2024

blackrock makes history with first blockchain issued municipal bond purchase

BlackRock's ETF has made a historic purchase of the first municipal bond issued via blockchain, acquired from Franklin Township, Ohio, utilizing the Provenance Blockchain platform. This initiative highlights blockchain's potential to enhance efficiency, transparency, and reduce costs in bond issuance, aligning with BlackRock's vision for digital finance. The bond will fund significant infrastructure projects, showcasing the asset manager's commitment to integrating traditional finance with emerging technologies.

Crypto News Flash

BlackRock, Inc. USA Amy Parker Larry Fink

Finance & Economy, News Article

16:31 19.12.2024

XRP poised for significant gains as resistance level approaches breakthrough

Analyst Ali Martinez is bullish on XRP, predicting a potential 57% surge to $4 if it surpasses the $2.60 resistance level, currently trading at $2.55. He also notes that long-term Bitcoin holders are reducing positions, suggesting a possible market top, with Bitcoin at $104,919. Meanwhile, Ethereum, trading at $3,866, may be poised for a significant rally as long-term holders enter the belief phase.

dailyhodl.com

Ethereum USD Bitcoin USD Ali Martinez Show more

Crypto, Social Media Post

16:30 19.12.2024

Novartis to close MorphoSys sites in Boston and Munich cutting 330 jobs

Novartis is set to close its sites in Munich and Boston, resulting in the loss of 330 jobs, following its $2.9 billion acquisition of MorphoSys. The closures are expected to be completed by the end of 2025. This move comes as Novartis continues to expand its oncology portfolio and engage in various licensing deals.

BioSpace

United States Dollar Incyte Corp Novartis AG USA CHE Show more

Finance & Economy, News Article

16:30 19.12.2024

solana dapp revenue surges 15x in 2024 driven by meme coins and defi

Solana's DApp revenue skyrocketed 15x in 2024, reaching $92 million, driven by meme coins and DeFi protocols. Meme coin DApps generated $509 million, with Pump.fun alone earning $106 million in November, despite facing criticism and a revenue drop after suspending its livestreaming feature. DeFi platforms like Raydium and Jupiter also contributed significantly, with Raydium capturing 86% of spot DEX revenue.

Cryptonews

United States Dollar Telegram Inu USD Raydium KRW Veronika Rinecker Show more

Finance & Economy, Market Report

16:20 19.12.2024

ethereum withdrawals surge as price struggles to gain momentum

Ethereum has seen over 7.8 million ETH withdrawn from Binance, contributing to a total of 20.8 million ETH leaving centralized exchanges in two months. Despite this reduction in supply potentially signaling future price appreciation, ETH's price has struggled, currently sitting at $3,858, down 21.1% from its all-time high. Technical indicators suggest a possible short-term decline, with analysts predicting a drop to $3,400, while key support levels are identified at $3,200 and $3,000.

The Currency analytics

Deutsche Bank RV Global PP

Crypto, Market Report

16:20 19.12.2024

China's ensartinib gains FDA approval for lung cancer treatment

Xcovery Holdings' ensartinib, branded as Ensacove, has received FDA approval as a first-line treatment for ALK-positive non-small cell lung cancer, marking a significant milestone as the first innovative targeted lung cancer drug from a Chinese company to enter the U.S. market. While it shows a 44% reduction in progression or death compared to Pfizer's Xalkori, it faces stiff competition from established ALK inhibitors like Roche's Alecensa, which has demonstrated superior efficacy in previous studies. Despite its potential, Ensacove's market entry comes amid a landscape dominated by major pharmaceutical players.

Fierce Pharma

United States Dollar Chinese Yuan AstraZeneca PLC Hoffmann-La Roche AG CHN USA Show more

Healthcare, Market Report

16:20 19.12.2024

Trending

Subcategory:

Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Market Sentiment Analysis Corporate Responsibility & ESG Central Bank Actions Decentralized Finance (DeFi) Innovations Cryptocurrency & Blockchain Regulations Tokenomics and Crypto Economics Banking Regulations Cryptocurrency Regulations Anti-Money Laundering (AML) Regulations Market Analysis and Predictions Funding Rounds & Investments Mergers & Acquisitions Cryptocurrency Developments SEC & Financial Compliance Inflation Rates & CPI Data Real Estate Investments Shareholder Activism

Countries:

USA CHE JPN AUS CAN IND GBR DEU AUT CHN HKG RUS LIE SAU BHR FRA ARG COL FIN NLD

Companies:

Coinbase Global, Inc. Ripples USD Solana USD BlackRock, Inc. Ethereum USD NVIDIA Corporation Cardano USD Tesla, Inc. Apple Inc. Credit Suisse Real Estate Fund Siat MicroStrategy Incorporated Amazon.com, Inc. Sumitomo Corp Google Inc. Bitwise Bitcoin ETF Chainlink USD Palantir Technologies Inc. Tether USDt CNY VAT Group AG Northern Star Resources Ltd

Currencies:

United States Dollar Euro Swiss Franc Japanese Yen Australian Dollar Canadian Dollar Colombian Peso Singapore Dollar Indian Rupee

People:

Dashboard News

Layout

Color mode

Theme mode

Layout settings

Dashboard News

Layout

Color mode

Theme mode

Layout settings

Global Modifications

Accessibility

Sidebar (requires page reload)

Navbar (requires page reload)

Layout (requires page reload)